Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-26

FDA Tentative Approval: PANTOPRAZOLE SODIUM — Supplemental Application (Civica, Inc.)

View source ↗

Summary

The FDA issued tentative approval for Civica, Inc.'s pantoprazole sodium supplemental application (NDA 209463), enabling tentative U.S. marketing approval for a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pantoprazole sodium (pantoprazole sodium)

Snippet

SUPPL TA for PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM)